Gene therapy for rheumatoid arthritis

Area of Science:

• Rheumatology and Gene Therapy
• Immunology and Molecular Biology

Background:

• Rheumatoid arthritis (RA) is a chronic, painful autoimmune disease with limited curative treatment options.
• Current therapies for RA primarily manage symptoms rather than addressing the underlying disease mechanisms.
• Advances in understanding RA pathophysiology have opened avenues for novel therapeutic strategies like gene therapy.

Purpose of the Study:

• To review the evidence supporting gene therapy as a treatment for arthritis.
• To highlight the progress and challenges in developing gene therapy for rheumatoid arthritis.

Main Methods:

• Review of preclinical studies in animal models of arthritis.
• Analysis of data from a completed Phase I clinical trial in women with end-stage RA.
• Inclusion of information on ongoing clinical trials for gene therapy in arthritis.

Main Results:

• Multiple animal studies demonstrate the potential of gene therapy in managing arthritis.
• A Phase I clinical trial involving nine women with end-stage RA was successfully completed.
• Two additional clinical trials investigating gene therapy for arthritis are currently underway.

Conclusions:

• Gene therapy presents a promising therapeutic avenue for rheumatoid arthritis, supported by preclinical and early clinical data.
• The primary limitation hindering the clinical application of gene therapy for arthritis is the transient nature of gene expression.
• Further research is needed to overcome the challenge of sustained gene expression for effective, long-term genetic treatment of RA.